CVS Group Regulatory News (CVSG)

10 October 2014

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Director Dealing

CVS, one of the UK's leading providers of veterinary services, announces that on 9 October 2014, Simon Innes, Chief Executive Officer of the Company, together with certain other employees of the Company, exercised options at 0.2 pence per share over an aggregate of 651,721 ordinary shares of 0.2 pence each in the Company (the "New Shares"), under the CVS Group Long Term Incentive Plan 2011/2014. Simon Innes exercised options over 333,710 ordinary shares of 0.2p each in the Company ("Ordinary Shares").

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 15 October 2014 ("Admission").

Following Admission, the Company's total issued share capital will consists of 58,903,242 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the total number of voting rights in the Company will be 58,903,242. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

On 9 October 2014, Simon Innes sold 333,710 Ordinary Shares at a price of 370p per Ordinary Share. Following the exercise and the sale, Simon Innes remains interested in 546,475 Ordinary Shares in the Company, representing 0.93 per cent in the total voting rights of the Company.

Contacts: